#johnson--johnson

[ follow ]
Healthcare
from24/7 Wall St.
2 weeks ago

Johnson & Johnson (NYSE: JNJ) Live Earnings Updates: Will The Dividend Champion Deliver?

Johnson & Johnson's stock is popular due to its 3.3% dividend yield and positive performance despite recent healthcare market sell-offs.
fromFortune
2 weeks ago

Tylenol parent Kenvue has a new CEO, and he has lots of work to do to mollify activist investors

Kenvue faces challenges in growth and profitability, leading to CEO resignation and strategic review after a 4% expected drop in net sales.
#investing
from24/7 Wall St.
2 months ago
Startup companies

If You Invested $25,000 In Johnson & Johnson (JNJ) 20 Years Ago, This Is How Much Cash From Dividends You Would Have Today

from24/7 Wall St.
2 months ago
Startup companies

If You Invested $25,000 In Johnson & Johnson (JNJ) 20 Years Ago, This Is How Much Cash From Dividends You Would Have Today

more#investing
Retirement
from24/7 Wall St.
2 months ago

2 Bulletproof Dividend Stocks to Buy in May

Dividend stocks are key for wealth building, offering income and reduced volatility, especially in uncertain economic conditions.
Marketing tech
fromwww.npr.org
3 months ago

'No More Tears' author discusses Johnson & Johnson's questionable business practices

Investigative journalist Gardiner Harris critiques Johnson & Johnson's trustworthiness by linking its business practices to health crises, notably cancer from baby powder.
Public health
fromNew York Post
3 months ago

How Johnson & Johnson has somehow survived scandal after scandal

The Tylenol poisonings in 1982 sparked widespread media coverage and a major crisis for Johnson & Johnson.
fromwww.nytimes.com
4 months ago

Johnson & Johnson Loses in Court Again in Bid to Settle Talc Cases

"The settlement proposal aimed to resolve ongoing lawsuits related to claims that Johnson & Johnson's talcum powder products caused cancer, which has been a contentious issue for years."
Law
Tech industry
fromBusiness Insider
4 months ago

An AI imaging firm says Johnson & Johnson stole its tech. Execs on both sides are expected to testify next week.

ChemImage is suing Johnson & Johnson for breach of contract regarding a failed partnership in surgical robotics.
from24/7 Wall St.
4 months ago

Johnson & Johnson Just Paid Investors: Here's How Much They Got

Investors favor dividend stocks as they provide both total return potential and a reliable stream of passive income, enhancing the overall investment success.
Startup companies
Public health
fromIrish Independent
10 months ago

Roy Butler inquest: Covid vaccine firm warns 'insufficient evidence' for link to fatal brain bleeds

Johnson & Johnson claims insufficient evidence links brain bleeds to their vaccine, despite some incidents reported after vaccination.
[ Load more ]